Subcutaneous insulin for diabetic ketoacidosis (DKA):
Montefiore subcutaneous insulin DKA protocol
University of Washington Subcutaneous Insulin DKA Protocol
Mount Sinai Hospital Emergency Room Guidance
Mount Sinai ICU/ Hospital Floors DKA Protocol
Treatment of diabetic ketoacidosis with subcutaneous insulin aspart
Diabetes Care 2004;27(8):1873‐8
Umpierrez GE, Cuervo R, Karabell A, Latif K, Freire AX, Kitabchi AE.
Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis
American Journal of Medicine 2004;117(5):291‐6
Umpierrez GE, Latif K, Stoever J, Cuervo R, Park L, Freire AX, et al.
Basal Bolus insulin therapy:
Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes (RABBIT 2 Trial)
Diabetes Care Sep 2007, 30 (9) 2181-2186
Guillermo E. Umpierrez, Dawn Smiley, Ariel Zisman, Luz M. Prieto, Andres Palacio, Miguel Ceron, Alvaro Puig, Roberto Mejia
Managing hyperglycemia and diabetes in patients receiving enteral feedings: A health system approach
Hospital Practice. 2015. 43(2) 74-78
Mabrey ME, Barton AB, Corsino L, Freeman SB, Davis ED, Bell EL, Setji TL.
Other resources:
Managing Diabetes and Hyperglycemia in the Hospital Setting: A Clinician’s Guide